Prasugrel, a third-generation P2Y12 receptor antagonist, in patients with coronary artery disease undergoing elective percutaneous coronary intervention - Isshiki, T; Kimura, T; Ogawa, H (Circ J, 2014)
, et al; PRASFIT-Elective Investigators.